Literature DB >> 21210794

Profiling hospitals by survival of patients with colorectal cancer.

Hui Zheng1, Wei Zhang, John Z Ayanian, Lawrence B Zaborski, Alan M Zaslavsky.   

Abstract

OBJECTIVE: To profile hospitals by survival rates of colorectal cancer patients in multiple periods after initial treatment. DATA SOURCES: California Cancer Registry data from 50,544 patients receiving primary surgery with curative intent for stage I-III colorectal cancer in 1994-1998, supplemented with hospital discharge abstracts. STUDY
DESIGN: We estimated a single Bayesian hierarchical model to quantify associations of survival to 30 days, 30 days to 1 year, and 1-5 years by hospital, adjusted for patient age, sex, race, stage, tumor site, and comorbidities. We compared two profiling methods for 30-day survival and four longer-term profiling methods by the fractions of hospitals with demonstrably superior survival profiles and of hospital pairs whose relative standings could be established confidently. PRINCIPAL
FINDINGS: Interperiod correlation coefficients of the random effects are (95 percent credible interval 0.27, 0.85), (0.20, 0.76), and (0.19, 0.82). The three-period model ranks 5.4 percent of pairwise comparisons by 30-day survival with at least 95 percent confidence, versus 3.3 percent of pairs using a single-period model, and 15-20 percent by weighted multiperiod methods.
CONCLUSIONS: The quality of care for colorectal cancer provided by a hospital system is somewhat consistent across the immediate postoperative and long-term follow-up periods. Combining mortality profiles across longer periods may improve the statistical reliability of outcome comparisons. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 21210794      PMCID: PMC3087866          DOI: 10.1111/j.1475-6773.2010.01222.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  28 in total

1.  The public release of performance data: what do we expect to gain? A review of the evidence.

Authors:  M N Marshall; P G Shekelle; S Leatherman; R H Brook
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

2.  Validity of information on comorbidity derived rom ICD-9-CCM administrative data.

Authors:  Hude Quan; Gerry A Parsons; William A Ghali
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

Review 3.  NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

Authors: 
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

4.  Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data.

Authors:  Harlan M Krumholz; Saif S Rathore; Jersey Chen; Yongfei Wang; Martha J Radford
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 6.  Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.

Authors:  Andrew G Renehan; Matthias Egger; Mark P Saunders; Sarah T O'Dwyer
Journal:  BMJ       Date:  2002-04-06

7.  Fostering accountable health care: moving forward in medicare.

Authors:  Elliott S Fisher; Mark B McClellan; John Bertko; Steven M Lieberman; Julie J Lee; Julie L Lewis; Jonathan S Skinner
Journal:  Health Aff (Millwood)       Date:  2009-01-27       Impact factor: 6.301

8.  Provider profiling and quality improvement efforts in coronary artery bypass graft surgery: the effect on short-term mortality among Medicare beneficiaries.

Authors:  Edward L Hannan; Mary S Vaughn Sarrazin; Donna R Doran; Gary E Rosenthal
Journal:  Med Care       Date:  2003-10       Impact factor: 2.983

9.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Relation of hospital volume to colostomy rates and survival for patients with rectal cancer.

Authors:  David C Hodgson; Wei Zhang; Alan M Zaslavsky; Charles S Fuchs; William E Wright; John Z Ayanian
Journal:  J Natl Cancer Inst       Date:  2003-05-21       Impact factor: 13.506

View more
  2 in total

1.  Assessment of variation in 30-day mortality following cancer surgeries among older adults across US hospitals.

Authors:  Allison Lipitz-Snyderman; Jessica A Lavery; Peter B Bach; Diane G Li; Annie Yang; Vivian E Strong; Ashley Russo; Katherine S Panageas
Journal:  Cancer Med       Date:  2020-01-09       Impact factor: 4.452

2.  Population-based cohort study comparing 30- and 90-day institutional mortality rates after colorectal surgery.

Authors:  B E Byrne; R Mamidanna; C A Vincent; O Faiz
Journal:  Br J Surg       Date:  2013-12       Impact factor: 6.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.